Skip to content

SURGI-TEC

Active Public limited companyfounded 1997active for 29 yearsPoortakkerstraat 43, 9051 GhentKBO/BCE: BE 0461.617.654 subsidiary of JOOSEN INVEST

Lifetime

20 annual accounts with figures on one time axis, 26 filings since 2000
peak €458,946 (2025)
€458,946▲ 5.4%
lowest -€118,612 (2012)
€15,592▼ 17.0%
peak €717,353 (2025)
€717,353▲ 2.2%
€549,439▲ 2.2%
peak 5.4 FTE (2008)
4.7 FTE▲ 11.9%
Board8 names since 2017
3 directorsJoosen Invest nv and 2 others
Owners3 names in the annual accounts
Documentsfilings and deeds
22-07-20269 days before the deadline
2025financial year
Staff from 4.2 FTE to 4.7 FTE1 statutory auditor reappointed 03-12Cash from €8,176 to €83,237

Key points

from the 2025 annual accounts

Equity

€717,353 ▲ 2.2%

SURGI-TEC has made a profit without a break since 2013.

Filings

26 annual accounts since 2000
AprilJune31 JulyOctober200020102020

Seven of the last ten came late. The 2018 accounts came latest: 90 days after the end of the period.

Board

5 joined · 1 left

Board changed. Latest change 01-10-2026 · 5 in office.

Checked score

92
Excellent
Financially stronger than 46% of micro companies in other manufacturing (NACE 32)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.3% across 1,141 companies (NACE 32, micro).

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.4%▲ +0.2 percentage points vs 07-2025highest value 09-2025: 0.4%● unchanged vs 08-2025highest value 10-2025: 0.4%● unchanged vs 09-2025highest value 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.3%▼ -0.1 percentage points vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.1%▼ -0.2 percentage points vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026

Financial strength
Strong

82=equity 56.6% of total assets
38+8short-term debt 42.4% · cash 6.6%
70-1return on assets 1.2%

Score breakdown

lowers risk
Founded in 1997
Equity €717,353 (56.6% of total assets)
Size: 4.7 FTE, total assets €1.3m
Legal form: public limited company
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 63% of them on solvency, 29% on liquidity, 44% on profitability and 47% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 17,041 companies had the same profile as SURGI-TEC has now. Each dot stands for 43 companies, two years later.

94.4%
were still trading
4.9%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of SURGI-TEC itself: 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,041 companies, not a prediction for SURGI-TEC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €65,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 1.65 (1.65 in 2024), above the usual 1.5. Short-term debt is 42.4% and cash 6.6% of total assets. 43.4% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Founded in 1997
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €717,353 (56.6% of total assets)
NBB · annual accounts
lowers risk · Size: 4.7 FTE, total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
9 days early
2024
23 days early
2023
16 days late
2022
56 days late
2021
61 days late
2020
68 days late
2019
32 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 29 days after the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 August (4 of the last 5 accounts filed within 40 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

MV
Managing director
SK
Managing director
JI
Director, Florentent Joosen
LR
Director
RB
ROSILE BV
Director, Benoit De Smet
MA
Auditor, Bart Dauwen
Board & ownership

Recent changes

4 directors appointed, 2 resignations Change of role: SCHEERLINCK KARIN GCV, from managing director to director · Resignations: JOOSEN INVEST NV and Raf Joosen · Permanent representatives: Florent Joosen, Karin Scheerlinck, Jan Joosen and Benoit De Smet · General meeting of 13-08-2026 · Gazette deed
1 statutory auditor reappointed Moore Audit BV (statutory auditor) · Permanent representatives: Bart Dauwen and Karina Scheerlinck · General meeting of 27-06-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0461617654
3 directors reappointed SCHEERLINCK KARIN (managing director), Joosen Raf (director) and JOOSEN INVEST (director) · Permanent representative: Karina Scheerlinck · General meeting of 18-09-2024 · Gazette deed
All 38 events

Comparable companies

same main activity, similar in size and age
Company
SURGI-TEC Ghent €1.3m €458,946 56.6% 4.7
PROPATH Gavere €0.9m €429,875 63.6% 4.1
E.D.S. ORTHOPEDIE Kontich €1.0m €501,603 2.3% 4
DENEWETH B. Hooglede €1.4m €412,353 75.3% 3.8
CEDEK MEDICAL Liège €1.2m €644,313 78.1% 4.8
BRULS ORTHOPEDIE Malmedy €1.3m €345,296 43.3% 5.2
Eqwal Enghien Soignies €1.4m €747,455 82.6% 5

These companies have the same main activity as SURGI-TEC: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €943,000 and €1.4m, founded between 1991 and 2003.

Official details

Source: KBO
Status
Active since 07-10-1997Normal situation
Activity
Manufacture of medical and dental instruments and suppliesNACE 32500
Joint committees
111Metal, mechanical and electrical engineering
209White-collar workers in metal manufacturing · annual accounts 2025
Establishment unit
2.083.619.5849051 Ghent, since 07-10-1997
Financial year end
31 December
Peppol
Reachable since 28-08-2025
Company details

Annual accounts 2025

≈ €1.1mestimated
€1.3m▲ 2.2%
Employeeson 31-12-2025
5=
Filing
Filed on 22-07-2026, 9 days before the end of the filing period
Financials

Insights on SURGI-TEC

SURGI-TEC has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €717,353 and a net result of €15,592.

Equity has been growing by about 2.9% per year since 2018. Its solvency ranks better than 60% of 144 sector peers (NACE 32, financial year 2025).

The computed 12-month bankruptcy probability is 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SURGI-TEC

What is the company number of SURGI-TEC?
The company number of SURGI-TEC is 0461.617.654. The VAT number is the same number with BE in front: BE 0461.617.654.
Where is SURGI-TEC based?
The registered office is at Poortakkerstraat 43, 9051 Ghent.Company details
What does SURGI-TEC do?
According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of SURGI-TEC?
SURGI-TEC is a public limited company (NV).
When was SURGI-TEC founded?
SURGI-TEC was founded on 07-10-1997.
Is SURGI-TEC still active?
Yes, SURGI-TEC is an active enterprise in the KBO register.
How many employees does SURGI-TEC have?
SURGI-TEC had an average of 4.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SURGI-TEC fall under?
In its 2025 annual accounts, SURGI-TEC states joint committees 111 (Metal, mechanical and electrical engineering) and 209 (White-collar workers in metal manufacturing).
What is the turnover of SURGI-TEC?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €458,946 and 2,275 comparable companies of the same size. It probably lies between €650,000 and €1.8m. It is a rough estimate.
Is SURGI-TEC profitable?
In financial year 2025, SURGI-TEC made a profit of €15,592.
Where can I find the annual accounts of SURGI-TEC?
SURGI-TEC filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SURGI-TEC due?
SURGI-TEC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.